StockWatch
·
ADITYA INFOTECH · Q2 FY27 · THE VERDICT

Beat and hedged: why Aditya's guiding margins down despite the blowout

Q2 revenue jumped 89.9% YoY and management raised full-year guidance, but the real story is margin discipline and controlled H2 slowdown. The street has already priced in the beat; what matters now is whether management delivers on the margin hedge.

Q2 FY27 resultsCPPLUSAditya Infotech Ltd13 Nov 2026 · 6 min read
Reported PAT

₹185.5 Cr

+165.1% YoY

Fire insurance loss

₹34.4 Cr

one-time charge

Pre-exceptional PAT

₹220 Cr

+214% YoY · 12.6% margin

Q2 EBITDA margin

17.6%

vs 14–15% FY27 guided

The 185.5 crore PAT looks like a blowout, but a ₹34.4 crore loss from the Kadapa plant fire (September 2026, fully insured) masks the organic story. Pre-exceptional profit was ₹220 crore — a robust 12.6% margin that validates underlying momentum. The real tension is not whether Aditya beat; it's what management is choosing to do with that beat.

What the quarter actually delivered

Revenue ₹1,746 crore (+89.9% YoY, +24.5% QoQ) and EBITDA ₹307 crore at 17.6% margin are both ahead of the 14–15% EBITDA guidance management reaffirmed on the call. H1 combined revenue ₹3,148 crore (+89.7%) reflects sustained momentum, with Q2 carrying 55% of the half-year load. Market share rose to 42% (from 30% at IPO), anchored by CP PLUS IP products now representing 79% of the portfolio (vs. 71% prior year), the highest-margin segment.

Management's claims vs. what holds up

Q2 revenue ₹1,746 Cr, up 89.9% YoY

Confirmed. H1 ₹3,148 Cr (+89.7%), market share 42% of ~₹7.5 Cr addressable market.

Supported

EBITDA margin 14–15% for FY27

H1 delivered 16.3%, Q2 delivered 17.6%, but management hedging H2 to ~13% due to SOC/memory cost volatility.

Supported but strategic

Revenue guidance raised to ₹6.5–6.8 Cr

Confirmed, raised from ₹6.0–6.5 Cr. H1 delivery of ₹3,148 Cr supports upper end of new range.

Supported

Market share 43–45% by FY27 end

At 42% now; three-tier brand strategy (CP PLUS Pro, NEXIVUE, EYRA) targets unorganized segment.

Credible

PAT margin raised to 9–10% for FY27

H1 delivered 11.5%. Post-QIP debt repayment lowers finance cost 41% YoY.

Supported

What changed on this call

New guidance and strategic shifts

Revenue guidance

Strong H1 momentum and market share gains justify upgrade. Growth accelerating.

Raised ₹6.0–6.5 Cr → ₹6.5–6.8 Cr

EBITDA margin guidance

Deliberate caution. Management prioritizing market share over margin expansion; H2 compression anticipated (~13%).

Maintained 14–15% despite H1 delivery of 16.3%

PAT margin guidance

Reflects pricing discipline and lower finance cost post-debt repayment.

Raised to 9–10% (from prior implied ~8%)

Market share target

Not new, but narrowed range signals high confidence. Implies 100–300 bps gain from 42% now.

Quantified and firmed at 43–45% by FY27 end

CapEx approval

Kadapa phase 3 + Greater Noida + backward integration plants. Housing trials Q4, commercial Q1 FY28.

₹650 Cr over 2–3 years for capacity doubling

The street's view — and where the stock sits

At ₹4,209 (as of Nov 12), Aditya trades 8.87% below its all-time high of ₹4,618.8 and well above its 52-week low of ₹1,348.3. The stock rallied sharply post-result on the beat and raised guidance, then cooled as the market digested the H2 margin hedge (implied ~13% EBITDA vs. H1 16.3%). Bulk deals on Nov 11 show mutual funds (Motilal Oswal, Kotak) accumulating (~₹582 Cr notional combined), but electronics company Dixon selling (~₹291 Cr), suggesting mixed sentiment near the highs. FII ownership ticked up to 6.35% (from 5.72%), but remains modest; DII at 13.61% and promoter holding 74.71%. The takeaway: the beat is real and widely credited, but the margin compression story is now the focus.

The bull-bear ledger
  • Q2 beat: revenue +89.9% YoY, EBITDA margin 17.6%

  • FY27 revenue guidance raised ₹6.0–6.5 Cr → ₹6.5–6.8 Cr (54–61% growth)

  • Market share momentum: 30% at IPO → 42% now → 45% target by FY27 end

  • Debt-free balance sheet post-QIP; finance cost down 41% YoY

  • Capacity doubling plan funded and on track (housing plant Q4 trials → Q1 FY28 commercial)

  • Only fully STOC-compliant Indian brand manufacturing (durable moat)

  • EBITDA margin guidance maintained 14–15% despite H1 16.3% — strategic hedge on H2 costs

  • H2 margin compression implied (~13% vs. H1 16.3%); SOC/DRAM volatility is primary risk

  • Competitive entry: 40+ STOC-certified brands; market share defense via price concessions possible

  • EYRA/NEXIVUE brand traction unproven; contribution not quantified

  • Export market entry 18–24 months out; nil near-term revenue visibility

  • Backward integration CapEx execution risk (₹650 Cr, 2–3 year timeline)

Risks, ranked by how much they should concern a holder

SOC and DRAM memory price volatility

High

Management flagged this as the reason for H2 margin compression. If prices spike further or stay elevated, EBITDA could fall below 14% guidance. This is the single most material near-term risk.

Competitive intensity from new STOC entrants

Medium

40+ new STOC-certified brands entering market. Though none from border nations yet certified, risk of share loss if entrants gain dealer/channel support. Could force price concessions or slow margin recovery in FY28–30.

Backward integration CapEx execution

Medium

₹650 Cr CapEx over 2–3 years is substantial. Cost inflation or construction delays could push capacity online later than planned, limiting growth in FY28–29 and deferring margin benefits.

EYRA and NEXIVUE brand ramp uncertainty

Medium

EYRA just hitting market (end-Nov). NEXIVUE contribution not quantified. If brands fail to gain traction, market share gains are all from CP PLUS; implies slower long-term TAM expansion.

Export market execution (18–24 month timeline)

Medium

Geographies still undefined. If execution slips or initial volume is immaterial, growth narrative loses a key catalyst for FY28–29.

One-time fire loss signals operational concentration

Low

Kadapa fire (fully insured, ₹34.4 Cr loss) underscores facility dependency. Greater Noida expansion partially de-risks, but concentration remains until capacity is truly duplicated.

What to watch next quarter
  • 1 · H2 EBITDA margin delivery vs. guided 14–15%

    The acid test. If Q3 or Q4 EBITDA margin falls below 13%, it signals cost headwinds faster than guided and resets the narrative downward. If margins hold 14–15%+, management has executed the hedge as planned. This is the highest-priority metric.

  • 2 · EYRA and NEXIVUE contribution to Q3 revenue

    Both brands need to show material contribution to validate the multi-brand strategy. If they remain immaterial, market share gains are all from CP PLUS, suggesting slower TAM expansion and limited runway.

  • 3 · FII/DII flows and insider activity post-bulk deals

    Mutual funds are accumulating (Motilal, Kotak), but Dixon sold ₹291 Cr on Nov 11 near ATH. Monitor Q3 shareholding pattern for trend confirmation. If insiders continue trimming near highs while funds add, that's a bearish divergence.

Aditya delivered a credible Q2 and raised FY27 guidance, but the market has already priced in the beat — the stock ran to all-time high of ₹4,618.8, then cooled 8.87% as the H2 margin compression story sank in. This is steady execution, not a step-change. Holders should track the pre-exceptional PAT run-rate (organic profit, stripping the fire loss) and watch whether H2 EBITDA margin stays true to the 14–15% guided range.

The number to anchor on: implied H2 EBITDA margin. If H1 was 16.3% and FY27 target is 14–15%, then H2 is ~12–13%. Every basis point of H2 margin delivery vs. that guide will signal whether management has the pricing power and cost control to defend share in an inflationary environment. That margin story is what resolves the bear debate next quarter.

Informational and educational content only. Not investment advice.